---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-015466"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T05:59:16.162761+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pieris Pharmaceuticals regains compliance with Nasdaq minimum bid price rule

## Summary
- Received Nasdaq letter on May 7, 2024 confirming compliance with Listing Rule 5550(a)(2).
- Closing bid price above $1.00 for 10 consecutive business days (April 23 to May 6, 2024).
- Matter is now closed; no further action required by the company.
- Stock symbol: PIRS, traded on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001437749-24-015466
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000143774924015466/0001437749-24-015466-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000143774924015466/pirs20240507_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-015466
- JSON: https://secwatch.observer/filing/0001437749-24-015466.json
- Plain text: https://secwatch.observer/filing/0001437749-24-015466.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.